The order carried out as a part of the project titled:
– ARG: “PRE-CLINICAL AND CLINICAL DEVELOPMENT OF ARGINASE INHBITOR FOR CANCER IMMUNOTHERAPY” (POIR.01.01.01-00-0415/17)
co-financed by European Union Funds and because of the competitiveness principle.
We hereby look for Contractor ready to perform:
Development of formulation and manufacturing of investigational medicinal product (IMP) in accordance to Good Manufacturing Practice for clinical trials of phase I & II.
On February 23, 2021, the Ordering Party has updated Appendix No. 5 in connection with the change of share capital. The deadline for submitting offers remains unchanged.